Primary Diffuse Large B-Cell Lymphoma of the Bone: Bendamustine and Rituximab Are Able to Overcome Resistant Disease

SpringerPlus - Germany
doi 10.1186/2193-1801-3-342
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC